Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment

Published:2019-06-24 Issue:9 Volume:34 Page:1597-1608
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Chavassieux Pascale¹^ORCID,Chapurlat Roland¹^ORCID,Portero‐Muzy Nathalie¹,Roux Jean‐Paul¹,Garcia Pedro²,Brown Jacques P³,Libanati Cesar⁴^ORCID,Boyce Rogely W⁵,Wang Andrea⁵,Grauer Andreas⁵

Affiliation:

1. INSERM UMR 1033 Université de Lyon Lyon France

2. Endocrinology Service, Osteoporosis Center University Hospital of Monterrey Monterrey Mexico

3. CHU de Quebec Research Centre and Department of Medicine Laval University Quebec Canada

4. UCB Pharma Brussels Belgium

5. Amgen Inc Thousand Oaks CA USA

Funder

Astellas Pharma Canada

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.3735

Reference33 articles.

1. Osteoporosis Prevention, Diagnosis, and Therapy

2. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

3. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

4. Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters

5. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of both sclerostin and DKK1 results in novel skull findings in the rat and non-human primate that is not observed with inhibition of sclerostin alone;Bone;2024-02

2. Τhe story of sclerostin inhibition: the past, the present, and the future;Hormones;2024-01-03

3. The Sequential Therapy in Osteoporosis;Indian Journal of Orthopaedics;2023-12

4. Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial;ACR Open Rheumatology;2023-11-20

5. The potential effect of romosozumab on perioperative management for instrumentation surgery;2023-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3